Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe/Moderate Coronavirus”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Early research (Phase 1)UnknownNCT04474340
What this trial is testing

COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients

Who this might be right for
Moderate COVID-19 Pneumonia, Severe COVID-19 PneumoniaPneumonia, Viral
Ministry of Health, Kuwait 300
Large-scale testing (Phase 3)Ended earlyNCT05639192
What this trial is testing

Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease

Who this might be right for
COVID-19
Apogenix GmbH 34
Testing effectiveness (Phase 2)Study completedNCT04707664
What this trial is testing

Sargramostim Use in COVID-19 to Recover Patient Health

Who this might be right for
Covid19SARS-CoV Infection
Partner Therapeutics, Inc. 600
Large-scale testing (Phase 3)WithdrawnNCT04361461
What this trial is testing

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Who this might be right for
Coronavirus InfectionsSARS-CoV 2SARS (Severe Acute Respiratory Syndrome)+1 more
Apsen Farmaceutica S.A.
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Testing effectiveness (Phase 2)WithdrawnNCT04355676
What this trial is testing

Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19

Who this might be right for
Coronavirus Infection
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)Study completedNCT04533347
What this trial is testing

Tafenoquine in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID 19 Disease
60 Degrees Pharmaceuticals LLC 86
Testing effectiveness (Phase 2)Ended earlyNCT05226533
What this trial is testing

Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.

Who this might be right for
COVID-19
Daewoong Pharmaceutical Co. LTD. 1
Not applicableWithdrawnNCT04953312
What this trial is testing

Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)

Who this might be right for
Severe/Moderate CoronavirusChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)UnknownNCT04321993
What this trial is testing

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

Who this might be right for
COVID-19
Lisa Barrett 363
Not applicableUnknownNCT05165979
What this trial is testing

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil

Who this might be right for
COVID-19Quality of LifeDisability Physical+1 more
Hospital Moinhos de Vento 650
Large-scale testing (Phase 3)Ended earlyNCT04952519
What this trial is testing

Efficacy of Amantadine Treatment in COVID-19 Patients

Who this might be right for
Patients With Moderate or Severe COVID-19
Noblewell 193
Not applicableStudy completedNCT04667936
What this trial is testing

Evaluation of Sedation in COVID-19 ARDS

Who this might be right for
Prone PositionSevere Acute Respiratory Syndrome Coronavirus 2Hypnotics and Sedatives+1 more
Goethe University 114
Not applicableEnded earlyNCT04619719
What this trial is testing

Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia

Who this might be right for
Covid19
Legacy Health System 27
Large-scale testing (Phase 3)Ended earlyNCT04928430
What this trial is testing

Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Who this might be right for
COVID-19
Xenothera SAS 290
Testing effectiveness (Phase 2)Active Not RecruitingNCT04565665
What this trial is testing

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Who this might be right for
COVID-19 InfectionCOVID-19-Associated Acute Respiratory Distress SyndromeHematopoietic and Lymphoid Cell Neoplasm+2 more
M.D. Anderson Cancer Center 65
Large-scale testing (Phase 3)WithdrawnNCT04575064
What this trial is testing

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Moderate and Severe COVID-19
Professor Dr. Bernd Mühlbauer
Post-approval studies (Phase 4)Ended earlyNCT04362332
What this trial is testing

Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19

Who this might be right for
COVID-19
UMC Utrecht 25
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04679415
What this trial is testing

Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19
ImmuneMed, Inc. 63
Next Page